CD274 and acute myeloid leukemia: Another study revealed the implication of ExoPD-L1 in acute myeloid leukemia (AML) immune evasion by suppressing natural killer (NK) cell activation and inhibiting their cytotoxicity, probably through the activation of the PD-1/PD-L1 pathway [49].